Free Trial

Cingulate (CINGW) Competitors

$0.04 0.00 (-0.26%)
(As of 11:02 AM ET)

CINGW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, and CEROW

Should you be buying Cingulate stock or one of its competitors? The main competitors of Cingulate include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and CERo Therapeutics (CEROW). These companies are all part of the "biotechnology" industry.

Cingulate vs.

Cingulate (NASDAQ:CINGW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, valuation, institutional ownership, dividends, community ranking, analyst recommendations and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CingulateN/AN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

In the previous week, Cingulate's average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Cingulate Neutral
180 Life Sciences Neutral

Company Net Margins Return on Equity Return on Assets
CingulateN/A N/A N/A
180 Life Sciences N/A N/A N/A

Cingulate and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
CingulateN/AN/A
180 Life SciencesN/AN/A

Summary

Cingulate and 180 Life Sciences tied by winning 0 of the 0 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CINGW vs. The Competition

MetricCingulateBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$202.11M$5.13B$9.28B
Dividend YieldN/A3.54%4.81%4.06%
P/E RatioN/A316.48135.2417.51
Price / SalesN/A15,204.511,174.53134.92
Price / CashN/A11.6740.4837.95
Price / BookN/A7.264.884.94
Net IncomeN/A-$18.52M$118.56M$225.30M
7 Day PerformanceN/A181.94%14.97%-1.11%
1 Month PerformanceN/A131.30%15.07%7.29%
1 Year PerformanceN/A112.50%34.31%23.06%

Cingulate Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CINGW
Cingulate
N/A$0.04
-0.3%
N/A+56.0%$0.00N/A0.0013
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A+41.0%$0.00N/A0.007Positive News
Gap Down
SXTPW
60 Degrees Pharmaceuticals
N/A$0.02
-51.0%
N/AN/A$0.00$502,409.000.002Positive News
Gap Down
High Trading Volume
DRTSW
Alpha Tau Medical
N/A$0.20
-20.4%
N/A+4.1%$0.00N/A0.0080News Coverage
Positive News
Gap Down
WENAW
Anew Medical
N/A$0.04
-0.3%
N/AN/A$0.00N/A0.00N/AGap Down
APLMW
Apollomics
N/A$0.01
flat
N/A-72.3%$0.00N/A0.0059Gap Up
BCTXW
BriaCell Therapeutics
N/A$0.35
-14.8%
N/A-80.9%$0.00N/A0.008Gap Down
CDIOW
Cardio Diagnostics
N/A$0.12
+9.5%
N/A-48.0%$0.00$35,688.000.007Positive News
Gap Up
High Trading Volume
CTCXW
Carmell
N/A$0.05
flat
N/AN/A$0.00$32,839.000.009Positive News
Gap Down
CELUW
Celularity
N/A$0.02
flat
N/A+196.3%$0.00$48.20M0.00220Positive News
Gap Up
High Trading Volume
CEROW
CERo Therapeutics
N/A$0.02
flat
N/AN/A$0.00N/A0.008Gap Down

Related Companies and Tools


This page (NASDAQ:CINGW) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners